Author:
Kim Minhyung,Barone Tara A.,Fedtsova Natalia,Gleiberman Anatoli,Wilfong Chandler D.,Alosi Julie A.,Plunkett Robert J.,Gudkov Andrei,Skitzki Joseph J.
Funder
Roswell Park Cancer Institute and National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference29 articles.
1. Andratschke N, Grosu AL, Molls M, Nieder C (2001) Perspectives in the treatment of malignant gliomas in adults. Anticancer Res 21:3541–3550
2. Lefranc F, Rynkowski M, DeWitte O, Kiss R (2009) Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg 34:3–35
3. Nieder C, Adam M, Molls M, Grosu AL (2006) Therapeutic options for recurrent high-grade glioma in adult patients: recent advances. Crit Rev Oncol 60:181–193. doi: 10.1016/j.critrevonc.2006.06.007
4. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173. doi: 10.1016/j.ccr.2006.02.019
5. Zustovich F, Cartei G, Ceravolo R, Zovato S, Della Puppa A, Pastorelli D, Mattiazzi M, Bertorelle R, Gardiman MP (2007) A phase I study of cisplatin, temozolomide and thalidomide in patients with malignant brain tumors. Anticancer Res 27:1019–1024
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献